美国 · SEC FORM 4
ASTROTECH Corp
ASTC · Nasdaq · CIK 0001001907 · Healthcare · Scientific & Technical Instruments
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
21 同一窗口内观察到的 Form 4 交易行
0 sales · 21 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-05-29 · Becker James Frank.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -8.3%
- 3M
- -26.1%
- 6M
- +79.1%
- 12M
- +36.5%
波动率与流动性
- 波动率
- 356.4%
- Beta
- —
- 平均每日成交额
- USD 891,847
估值
- 市值
- USD 13.7M
- P/E
- —
基本面
- 利润率
- —
- ROE
- -89.2%
- 细分行业
- Scientific & Technical Instruments
市场数据
价格数据截至：2026-10-08 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, ROE · 财年截止日：2026-06-30 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-09-23 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 88,319
- 上期报告
- 101,853
- 日均成交量
- 37,982
- 回补天数
- 2.3
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-05-29 | Becker James Frank | 买入 (P) | Common Stock | 1,100 | USD 9.82 | USD 10,802 | SEC 申报 ↗ |
| 2024-05-28 | Becker James Frank | 买入 (P) | Common Stock | 934 | USD 9.50 | USD 8,873 | SEC 申报 ↗ |
| 2024-05-21 | Wilkinson Thomas Wiley | 买入 (P) | Common Stock | 1,109 | USD 9.50 | USD 10,536 | SEC 申报 ↗ |
| 2024-03-15 | MCFARLAND ROBERT N | 买入 (P) | Common Stock | 1,185 | USD 8.50 | USD 10,072 | SEC 申报 ↗ |
| 2024-03-15 | Russler Daniel T Jr | 买入 (P) | Common Stock | 387 | USD 8.42 | USD 3,259 | SEC 申报 ↗ |
| 2024-03-15 | Becker James Frank | 买入 (P) | Common Stock | 649 | USD 8.25 | USD 5,354 | SEC 申报 ↗ |
| 2024-03-13 | Becker James Frank | 买入 (P) | Common Stock | 839 | USD 8.16 | USD 6,846 | SEC 申报 ↗ |
| 2024-03-13 | Wilkinson Thomas Wiley | 买入 (P) | Common Stock | 1,300 | USD 8.28 | USD 10,764 | SEC 申报 ↗ |
| 2024-03-12 | Russler Daniel T Jr | 买入 (P) | Common Stock | 500 | USD 8.29 | USD 4,145 | SEC 申报 ↗ |
| 2024-03-12 | Becker James Frank | 买入 (P) | Common Stock | 958 | USD 8.14 | USD 7,798 | SEC 申报 ↗ |
| 2023-12-29 | MCFARLAND ROBERT N | 买入 (P) | Common Stock | 21 | USD 8.34 | USD 175 | SEC 申报 ↗ |
| 2023-12-27 | MCFARLAND ROBERT N | 买入 (P) | Common Stock | 1,200 | USD 8.19 | USD 9,828 | SEC 申报 ↗ |
| 2023-12-11 | Russler Daniel T Jr | 买入 (P) | Common Stock | 650 | USD 7.65 | USD 4,972 | SEC 申报 ↗ |
| 2023-11-28 | Hinojosa Jaime | 买入 (P) | Common Stock | 1,000 | USD 8.19 | USD 8,190 | SEC 申报 ↗ |
| 2023-11-28 | Becker James Frank | 买入 (P) | Common Stock | 490 | USD 8.13 | USD 3,984 | SEC 申报 ↗ |
Form 4 申报证据
26 transaction lines in the latest 365-day window; 119 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Winn Charles Arch | 奖励／授予 (A) | Common Stock | 1,331 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-30 | Wilkinson Tom | 奖励／授予 (A) | Common Stock | 1,331 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-30 | Stober Eric | 奖励／授予 (A) | Common Stock | 1,473 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (26 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Winn Charles Arch | 奖励／授予 (A) | Common Stock | 1,331 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-30 | Wilkinson Tom | 奖励／授予 (A) | Common Stock | 1,331 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-30 | Stober Eric | 奖励／授予 (A) | Common Stock | 1,473 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-30 | MCFARLAND ROBERT N | 奖励／授予 (A) | Common Stock | 1,331 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-30 | Kreps Matthew | 奖励／授予 (A) | Common Stock | 1,114 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-30 | Halinski John William | 奖励／授予 (A) | Common Stock | 1,331 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-01 | Winn Charles Arch | 奖励／授予 (A) | Common Stock | 2,150 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-01 | Winn Charles Arch | 奖励／授予 (A) | Common Stock | 2,150 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-22 | Badugu Nihanth | 奖励／授予 (A) | Common Stock | 5,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-22 | Badugu Nihanth | 奖励／授予 (A) | Common Stock | 5,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-16 | Stober Eric | 奖励／授予 (A) | Common Stock | 2,150 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-16 | Halinski John William | 奖励／授予 (A) | Common Stock | 2,150 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-16 | Stober Eric | 奖励／授予 (A) | Common Stock | 2,150 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-16 | Kreps Matthew | 奖励／授予 (A) | Common Stock | 2,150 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-16 | Halinski John William | 奖励／授予 (A) | Common Stock | 2,150 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-09 | MCFARLAND ROBERT N | 奖励／授予 (A) | Common Stock | 1,055 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-09 | Winn Charles Arch | 奖励／授予 (A) | Common Stock | 1,055 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-09 | Wilkinson Tom | 奖励／授予 (A) | Common Stock | 1,055 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-09 | Stober Eric | 奖励／授予 (A) | Common Stock | 1,167 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-09 | MCFARLAND ROBERT N | 奖励／授予 (A) | Common Stock | 1,055 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-09 | Halinski John William | 奖励／授予 (A) | Common Stock | 1,055 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-14 | Halinski John William | 奖励／授予 (A) | Common Stock | 6,006 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-14 | Wilkinson Tom | 奖励／授予 (A) | Common Stock | 6,006 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-14 | Winn Charles Arch | 奖励／授予 (A) | Common Stock | 6,006 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-14 | Stober Eric | 奖励／授予 (A) | Common Stock | 6,006 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-14 | MCFARLAND ROBERT N | 奖励／授予 (A) | Common Stock | 6,006 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ASTC |
| CIK | 0001001907 |
| 行业 | Healthcare |
| 细分行业 | Scientific & Technical Instruments Yahoo Finance |
| SEC SIC | 3826 Laboratory Analytical Instruments |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 119 transaction lines from 2020-12-23 to 2026-09-30 45 P purchase lines · 2 S sale lines · 72 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.